Interactive effect of apolipoprotein E genotype and age on hippocampal activation during memory processing in healthy adults

Archives of General Psychiatry

Volumn 69, Issue 8, 2012, Pages 804-813

  Nichols, Lisa M ^a   Masdeu, Joseph C ^a   Mattay, Venkata S ^a   Kohn, Philip ^a   Emery, Matthew ^a   Sambataro, Fabio ^a   Kolachana, Bhaskar ^a   Elvevåg, Brita ^a   Kippenhan, Shane ^a   Weinberger, Daniel R ^a   Berman, Karen F ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGE; AGED; ARTICLE; BOLD SIGNAL; EPISODIC MEMORY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; MALE; TASK PERFORMANCE;

ADULT; AGE FACTORS; AGED; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BRAIN MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, EPISODIC; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84865530442     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.1893     Document Type: Article

References (73)

1. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A. 2006;103(15):5644-5651.
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921-923. (Pubitemid 23275809)
3. Bondi MW, Houston WS, Eyler LT, Brown GG. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology. 2005;64(3):501-508. (Pubitemid 40189870)
4. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000;343(7):450-456. (Pubitemid 30646483)
5. Borghesani PR, Johnson LC, Shelton AL, Peskind ER, Aylward EH, Schellenberg GD, Cherrier MM. Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers. Neurobiol Aging. 2008;29(7):981-991. (Pubitemid 351697985)
6. Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol. 2005;62(12):1881-1888. (Pubitemid 41785082)
7. Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging. 2007;28(2):238-247. (Pubitemid 44894633)
8. Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA. The influence of Alzheimer disease family history and apolipoprotein E ε4 on mesial temporal lobe activation. J Neurosci. 2006;26(22):6069-6076. (Pubitemid 44334754)
9. Mondadori CR, de Quervain DJ, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF, Boesiger P, Hock C, Nitsch RM, Papassotiropoulos A, Henke K. Better memory and neural efficiency in young apolipoprotein E ε4 carriers. Cereb Cortex. 2007;17(8):1934-1947. (Pubitemid 47216511)
10. Trivedi MA, Schmitz TW, Ries ML, Hess TM, Fitzgerald ME, Atwood CS, Rowley HA, Asthana S, Sager MA, Johnson SC. fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease. Neuropsychologia. 2008;46(6):1667-1678.
11. Trivedi MA, Schmitz TW, Ries ML, Torgerson BM, Sager MA, Hermann BP, Asthana S, Johnson SC. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a crosssectional study. BMC Med. 2006;4:1 doi:10.1186/1741-7015-4-. 1.
12. Dennis NA, Browndyke JN, Stokes J, Need A, Burke JR, Welsh-Bohmer KA, Cabeza R. Temporal lobe functional activity and connectivity in young adult APOE ε4 carriers. Alzheimers Dement. 2010;6(4):303-311.
13. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE. Distinct patterns of brain activity in young carriers of the APOE-ε4 allele. ProcNatl Acad Sci U S A. 2009;106(17):7209-7214.
14. Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, Wilcock GK, Beckmann CF, Smith SM, Matthews PM, Mackay CE. Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage. 2011;54(1):602-610.
15. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180-184. (Pubitemid 24174658)
16. Berlau DJ, Corrada MM, Head E, Kawas CH. APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology. 2009;72(9):829-834.
17. Alexander DM, Williams LM, Gatt JM, Dobson-Stone C, Kuan SA, Todd EG, Schofield PR, Cooper NJ, Gordon E. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol Psychol. 2007;75(3):229-238. (Pubitemid 46915557)
18. Hynd MR, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int. 2004;45(5):583-595. (Pubitemid 38844879)
19. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 2007;55(5):697-711. (Pubitemid 47321079)
20. Wisdom NM, Callahan JL, Hawkins KA. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol Aging . 2011;32(1):63-74.
21. First M, Frances A, Pincos H. DSM-IV-TR Handbook of Differential Diagnosis. Washington, DC: American Psychiatric Publishing, Inc; 2002.
22. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci. 1993;114(1):7-12. (Pubitemid 23025201)
23. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM; APOE and Alzheimer Disease Meta Analysis Consortium. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: ameta-analysis. JAMA. 1997;278(16):1349-1356. (Pubitemid 27449696)
24. Nathoo N, Chetty R, van Dellen JR, Barnett GH. Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. Mol Pathol. 2003;56(3):132-136. (Pubitemid 36724224)
25. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9(1):97-113.
26. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol. 1992;9(3):155-167.
27. Koch W, Ehrenhaft A, Griesser K, Pfeufer A, Müller J, Schömig A, Kastrati A. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med. 2002;40(11):1123-1131. (Pubitemid 36032659)
28. Wechsler D, Stone CP. Wechsler Memory Scale. San Antonio, TX: Psychological Corp; 1945.
29. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci. 2003;23(17):6690-6694. (Pubitemid 36951196)
30. Lang PJ, Bradley MM, Cuthbert BN. Emotion and motivation: measuring affective perception. J Clin Neurophysiol. 1998;15(5):397-408. (Pubitemid 28515976)
31. Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999;7(4):254-266. (Pubitemid 29269964)
32. Murty VP, Sambataro F, Das S, Tan HY, Callicott JH, Goldberg TE, Meyer-Lindenberg A, Weinberger DR, Mattay VS. Age-related alterations in simple declarative memory and the effect of negative stimulus valence. J Cogn Neurosci. 2009;21(10):1920-1933.
33. Maldjian JA, Laurienti PJ, Burdette JH. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage. 2004;21(1):450-455. (Pubitemid 38115035)
34. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19(3):1233-1239. (Pubitemid 36918259)
35. Cabeza R, Grady CL, Nyberg L, McIntosh AR, Tulving E, Kapur S, Jennings JM, Houle S, Craik FI. Age-related differences in neural activity during memory encoding and retrieval: a positron emission tomography study. J Neurosci. 1997;17(1):391-400. (Pubitemid 27008878)
36. Grady CL, McIntosh AR, Rajah MN, Beig S, Craik FI. The effects of age on the neural correlates of episodic encoding. Cereb Cortex. 1999;9(8):805-814. (Pubitemid 30004593)
37. Grady CL, McIntosh AR, Horwitz B, Maisog JM, Ungerleider LG, Mentis MJ, Pietrini P, Schapiro MB, Haxby JV. Age-related reductions in human recognition memory due to impaired encoding. Science. 1995;269(5221):218-221.
38. Fischer H, Nyberg L, Bäckman L. Age-related differences in brain regions supporting successful encoding of emotional faces. Cortex. 2010;46(4):490-497.
39. Morcom AM, Good CD, Frackowiak RS, Rugg MD. Age effects on the neural correlates of successful memory encoding. Brain. 2003;126(pt 1):213-229. (Pubitemid 36068571)
40. Meulenbroek O, Kessels RP, de Rover M, Petersson KM, Rikkert MG, Rijpkema M, Fernández G. Age-effects on associative object-location memory. Brain Res. 2010;1315:100-110.
41. Leshikar ED, Gutchess AH, Hebrank AC, Sutton BP, Park DC. The impact of increased relational encoding demands on frontal and hippocampal function in older adults. Cortex. 2010;46(4):507-521.
42. Gutchess AH, Welsh RC, Hedden T, Bangert A, Minear M, Liu LL, Park DC. Aging and the neural correlates of successful picture encoding: frontal activations compensate for decreased medial-temporal activity. J Cogn Neurosci. 2005;17(1):84-96.
43. Davis SW, Dennis NA, Daselaar SM, Fleck MS, Cabeza R. Que PASA? the posterior-anterior shift in aging. Cereb Cortex. 2008;18(5):1201-1209.
44. Phillips LH, Andrés P. The cognitive neuroscience of aging: new findings on compensation and connectivity. Cortex. 2010;46(4):421-424.
45. Grady CL, Maisog JM, Horwitz B, Ungerleider LG, Mentis MJ, Salerno JA, Pietrini P, Wagner E, Haxby JV. Age-related changes in cortical blood flow activation during visual processing of faces and location. J Neurosci. 1994;14(3, pt 2):1450-1462. (Pubitemid 24079997)
46. Ances BM, Liang CL, Leontiev O, Perthen JE, Fleisher AS, Lansing AE, Buxton RB. Effects of aging on cerebral blood flow, oxygen metabolism, and blood oxygenation level dependent responses to visual stimulation. Hum Brain Mapp. 2009;30(4):1120-1132.
47. Bangen KJ, Restom K, Liu TT, Jak AJ, Wierenga CE, Salmon DP, Bondi MW. Differential age effects on cerebral blood flow and BOLD response to encoding: associations with cognition and stroke risk. Neurobiol Aging. 2009;30(8):1276-1287.
48. D'Esposito M, Deouell LY, Gazzaley A. Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging. Nat Rev Neurosci. 2003;4(11):863-872. (Pubitemid 37351426)
49. Walhovd KB, Westlye LT, Amlien I, Espeseth T, Reinvang I, Raz N, Agartz I, Salat DH, Greve DN, Fischl B, Dale AM, Fjell AM. Consistent neuroanatomical age-related volume differences across multiple samples. Neurobiol Aging. 2011;32(5):916-932.
50. Samanez-Larkin GR, D'Esposito M. Group comparisons: imaging the aging brain. Soc Cogn Affect Neurosci. 2008;3(3):290-297.
51. Burggren AC, Zeineh MM, Ekstrom AD, Braskie MN, Thompson PM, Small GW, Bookheimer SY. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage. 2008;41(4):1177-1183.
52. Mueller SG, Weiner MW. Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus. 2009;19(6):558-564.
53. Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Dale AM, Stern CE, Blacker D, Albert MS, Sperling RA. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol. 2004;56(1):27-35. (Pubitemid 38857357)
54. Miller SL, Fenstermacher E, Bates J, Blacker D, Sperling RA, Dickerson BC. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J Neurol Neurosurg Psychiatry. 2008;79(6):630-635. (Pubitemid 351829432)
55. Xu PT, Li YJ, Qin XJ, Kroner C, Green-Odlum A, Xu H, Wang TY, Schmechel DE, Hulette CM, Ervin J, Hauser M, Haines J, Pericak-Vance MA, Gilbert JRA. A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci. 2007;36(3):313-331. (Pubitemid 47633197)
56. Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A. 2009;106(16):6820-6825.
57. Cherbuin N, Leach LS, Christensen H, Anstey KJ. Neuroimaging and APOE genotype: a systematic qualitative review. Dement Geriatr Cogn Disord. 2007;24(5):348-362. (Pubitemid 350036691)
58. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE. ApoE promotes the proteolytic degradation of Abeta. Neuron. 2008;58(5):681-693. (Pubitemid 351778466)
59. Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507-537.
60. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet. 1996;14(1):55-61. (Pubitemid 26301547)
61. Martínez-González NA, Sudlow CL. Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2006;77(12):1329-1335.
62. Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma. 2008;25(4):279-290. (Pubitemid 351457767)
63. Han SD, Bondi MW. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement. 2008;4(4):251-254. (Pubitemid 351866117)
64. Wright RO, Hu H, Silverman EK, Tsaih SW, Schwartz J, Bellinger D, Palazuelos E, Weiss ST, Hernandez-Avila M. Apolipoprotein E genotype predicts 24-month Bayley scales infant development score. Pediatr Res. 2003;54(6):819-825. (Pubitemid 37456545)
65. Puttonen S, Elovainio M, Kivimäki M, Lehtimäki T, Keltikangas-Järvinen L. The combined effects of apolipoprotein E polymorphism and low-density lipoprotein cholesterol on cognitive performance in young adults. Neuropsychobiology. 2003;48(1):35-40. (Pubitemid 36928713)
66. Yu YW, Lin CH, Chen SP, Hong CJ, Tsai SJ. Intelligence and event-related potentials for young female human volunteer apolipoprotein E ε4 and non-epsilon4 carriers. Neurosci Lett. 2000;294(3):179-181.
67. Bunce D, Anstey KJ, Burns R, Christensen H, Easteal S. Does possession of apolipoprotein E 4 benefit cognitive function in healthy young adults? Neuropsychologia. 2011;49(7):1693-1697.
68. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Carothers A, Whalley LJ. Cognitive change and the APOE ε4 allele. Nature. 2002;418(6901): 932. doi:10.1038/418932a.
69. Brewer JB, Zhao Z, Desmond JE, Glover GH, Gabrieli JD. Making memories: brain activity that predicts how well visual experience will be remembered. Science. 1998;281(5380):1185-1187. (Pubitemid 28406292)
70. Prince SE, Dennis NA, Cabeza R. Encoding and retrieving faces and places: distinguishing process- and stimulus-specific differences in brain activity. Neuropsychologia. 2009;47(11):2282-2289.
71. Zeineh MM, Engel SA, Thompson PM, Bookheimer SY. Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science. 2003;299(5606):577-580. (Pubitemid 36135158)
72. Suthana NA, Krupa A, Donix M, Burggren A, Ekstrom AD, Jones M, Ercoli LM, Miller KJ, Siddarth P, Small GW, Bookheimer SY. Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease. Neuroimage. 2010;53(3):1077-1084.
73. Corder EH, Lannfelt L, Bogdanovic N, Fratiglioni L, Mori H. The role of APOE polymorphisms in late-onset dementias. Cell Mol Life Sci. 1998;54(9):928-934. (Pubitemid 28461682)